Nerlikar Hospitals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 22.50 Cr
as on 11-12-2024
- Revenue %
(FY 2022)
- Profit -4704.61%
(FY 2022)
- Ebitda -6244.26%
(FY 2022)
- Net Worth -2679.66%
(FY 2022)
- Total Assets 340.82%
(FY 2022)
About Nerlikar Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹22.50 Cr.
Vinayak Nerlikar, Bhavna Nerlikar, Shobha Nerlikar, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100MH2020PTC340655
- Company No.
340655
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jun 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nerlikar Hospitals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinayak Nerlikar  | Director | 15-Jun-2020 | Current |
| Bhavna Nerlikar | Director | 15-Jun-2020 | Current |
| Shobha Nerlikar | Director | 15-Jun-2020 | Current |
| Archis Nerlikar | Director | 15-Jun-2020 | Current |
Financial Performance of Nerlikar Hospitals.
Nerlikar Hospitals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 4704.61% decrease in profit. The company's net worth observed a substantial decline by a decrease of 2679.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nerlikar Hospitals?
Unlock access to Nerlikar Hospitals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Ario Pharma Private LimitedActive 6 years 10 months
Bhavna Nerlikar and Archis Nerlikar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tjsb Sahakari Bank Limited Creation Date: 02 Jul 2021 | ₹22.50 Cr | Open |
How Many Employees Work at Nerlikar Hospitals?
Unlock and access historical data on people associated with Nerlikar Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nerlikar Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nerlikar Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
